Laird Norton Wetherby Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$601K Buy
7,732
+8
+0.1% +$625 0.02% 513
2025
Q2
$604K Buy
+7,724
New +$576K 0.03% 506
2024
Q4
$617K Sell
8,336
-530
-6% -$37.1K 0.03% 468
2024
Q3
$585K Sell
8,866
-2,460
-22% -$179K 0.03% 507
2024
Q2
$1.05M Sell
11,326
-251
-2% -$22.2K 0.05% 344
2024
Q1
$1.11M Buy
11,577
+226
+2% +$19K 0.05% 340
2023
Q4
$866K Sell
11,351
-95
-0.8% -$6.61K 0.05% 387
2023
Q3
$793K Sell
11,446
-3,216
-22% -$258K 0.05% 390
2023
Q2
$1.38M Sell
14,662
-675
-4% -$58.7K 0.07% 271
2023
Q1
$1.27M Buy
15,337
+2,547
+20% +$200K 0.07% 282
2022
Q4
$954K Sell
12,790
-858
-6% -$66.1K 0.06% 338
2022
Q3
$1.13M Buy
13,648
+1,651
+14% +$159K 0.08% 256
2022
Q2
$1.14M Sell
11,997
-921
-7% -$95.3K 0.08% 266
2022
Q1
$1.52M Sell
12,918
-333
-3% -$37.4K 0.09% 220
2021
Q4
$1.72M Buy
13,251
+721
+6% +$84.1K 0.1% 195
2021
Q3
$1.42M Buy
12,530
+265
+2% +$30.2K 0.09% 215
2021
Q2
$1.27M Buy
12,265
+621
+5% +$58.5K 0.08% 242
2021
Q1
$973K Sell
11,644
-514
-4% -$43.5K 0.07% 258
2020
Q4
$1.11M Buy
12,158
+437
+4% +$36.2K 0.08% 247
2020
Q3
$935K Sell
11,721
-355
-3% -$27.7K 0.08% 234
2020
Q2
$834K Buy
12,076
+1,549
+15% +$110K 0.08% 249
2020
Q1
$662K Sell
10,527
-426
-4% -$30.7K 0.07% 257
2019
Q4
$852K Buy
10,953
+333
+3% +$26K 0.08% 249
2019
Q3
$779K Buy
10,620
+720
+7% +$50.6K 0.08% 267
2019
Q2
$610K Buy
9,900
+81
+0.8% +$4.9K 0.07% 331
2019
Q1
$626K Buy
9,819
+1,011
+11% +$57.7K 0.08% 306
2018
Q4
$450K Buy
8,808
+2,268
+35% +$115K 0.06% 357
2018
Q3
$379K Sell
6,540
-135
-2% -$6.6K 0.05% 435
2018
Q2
$323K Buy
6,675
+150
+2% +$7K 0.04% 450
2018
Q1
$303K Buy
6,525
+792
+14% +$34.4K 0.04% 479
2017
Q4
$215K Buy
5,733
+69
+1% +$2.53K 0.03% 580
2017
Q3
$206K Buy
5,664
+447
+9% +$17K 0.03% 559
2017
Q2
$206K Buy
+5,217
New +$190K 0.04% 521
2016
Q4
Sell
-5,871
Closed -$236K 531
2016
Q3
$236K Buy
+5,871
New +$221K 0.05% 448

Other funds holding EW